Thrivent Funds > Thrivent Series Fund Inc
THRIVENT HEALTHCARE PORTFOLIO
$277.08M
Avg Monthly Net Assets
$277.92M
Total Assets
$883K
Total Liabilities
$277.04M
Net Assets
THRIVENT HEALTHCARE PORTFOLIO is an Underlying fund in Thrivent Series Fund Inc
from Thrivent Funds,
based in Minnesota,
United States of America.
The fund has one share class
and monthly net assets of $277.08M.
On August 27th, 2024 it reported 58 holdings, the largest
being Lilly Eli & Co (11.3%), Unitedhealth Group Inc (8.7%) and Johnson & Johnson (7.5%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| Class A | C000062736 | QTHCPX |
Holdings
From latest NPORT-P, filed August 27th, 2024 for period ending June 28th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| Abbott Laboratories (Advanced Medical Optics Inc) | Long | Equity-common | US | $10M | 100K | 3.75 |
| AbbVie, Inc. (Abbvie Inc) | Long | Equity-common | US | $13M | 78K | 4.80 |
| ABIOMED, Inc., CVR (Johnson & Johnson) | Long | Equity-common | US | $7K | 7K | 0.00 |
| Align Technology, Inc. (Align Technology Inc) | Long | Equity-common | US | $2M | 9K | 0.77 |
| Amgen, Inc. (Amgen Inc) | Long | Equity-common | US | $10M | 31K | 3.50 |
| AstraZeneca plc ADR | Long | Equity-common | GB | $949K | 12K | 0.34 |
| Avantor, Inc. (Avantor Inc) | Long | Equity-common | US | $2M | 78K | 0.59 |
| Baxter International, Inc. (Baxter International Inc) | Long | Equity-common | US | $2M | 69K | 0.83 |
| Bio-Techne Corporation | Long | Equity-common | US | $2M | 27K | 0.70 |
| Biogen, Inc. (Biogen Inc) | Long | Equity-common | US | $2M | 7K | 0.58 |
| Boston Scientific Corporation | Long | Equity-common | US | $6M | 82K | 2.28 |
| Cencora, Inc. (Amerisourcebergen Corp) | Long | Equity-common | US | $4M | 18K | 1.44 |
| Centene Corporation (CENTENE CORP DEL) | Long | Equity-common | US | $1M | 19K | 0.45 |
| Charles River Laboratories International, Inc. (Charles RIVer Laboratories International Inc) | Long | Equity-common | US | $2M | 10K | 0.73 |
| Cigna Group (Cigna Corporation New) | Long | Equity-common | US | $3M | 8K | 0.93 |
| Cooper Companies, Inc. (Cooper Cos Inc/The) | Long | Equity-common | US | $2M | 20K | 0.62 |
| CVS Health Corporation | Long | Equity-common | US | $4M | 59K | 1.26 |
| Danaher Corporation | Long | Equity-common | US | $11M | 45K | 4.08 |
| Dexcom, Inc. (Dexcom Inc) | Long | Equity-common | US | $3M | 31K | 1.26 |
| Edwards Lifesciences Corporation | Long | Equity-common | US | $3M | 37K | 1.23 |
| Elevance Health, Inc. (Wellpoint Inc) | Long | Equity-common | US | $6M | 10K | 2.05 |
| Eli Lilly & Company (Lilly Eli & Co) | Long | Equity-common | US | $31M | 35K | 11.29 |
| Encompass Health Corporation | Long | Equity-common | US | $986K | 11K | 0.36 |
| Enovis Corporation (Colfax Corp) | Long | Equity-common | US | $609K | 13K | 0.22 |
| Gilead Sciences, Inc. (Gilead Sciences Inc) | Long | Equity-common | US | $4M | 55K | 1.35 |
| GRAIL, Inc. (GRAIL Inc) | Long | Equity-common | US | $13K | 822 | 0.00 |
| Haemonetics Corporation (Haemonetics Corporation Mass) | Long | Equity-common | US | $652K | 8K | 0.24 |
| HCA Healthcare, Inc. (Hca Healthcare Inc) | Long | Equity-common | US | $4M | 13K | 1.51 |
| HealthEquity, Inc. (Healthequity Inc) | Long | Equity-common | US | $1M | 12K | 0.38 |
| Humana, Inc. (Humana Inc) | Long | Equity-common | US | $4M | 9K | 1.27 |
| IDEXX Laboratories, Inc. (Idexx Labs Inc) | Long | Equity-common | US | $2M | 5K | 0.87 |
| Illumina, Inc. (Illumina Inc) | Long | Equity-common | US | $515K | 5K | 0.19 |
| Intuitive Surgical, Inc. (IntuitIVe Surgical Inc) | Long | Equity-common | US | $9M | 20K | 3.28 |
| IQVIA Holding, Inc. (Iqvia Holdings Inc) | Long | Equity-common | US | $3M | 16K | 1.25 |
| Jazz Pharmaceuticals, Inc. (Jazz Pharmaceuticals Plc) | Long | Equity-common | IE | $1M | 11K | 0.42 |
| Johnson & Johnson | Long | Equity-common | US | $21M | 142K | 7.50 |
| Labcorp Holdings, Inc. (Labcorp Holdings Inc) | Long | Equity-common | US | $2M | 12K | 0.87 |
| Masimo Corporation | Long | Equity-common | US | $2M | 13K | 0.57 |
| McKesson Corporation (Lilly Eli & Co) | Long | Equity-common | US | $3M | 5K | 0.99 |
| Medtronic plc | Long | Equity-common | US | $4M | 55K | 1.56 |
| Merck & Company, Inc. (MERCK & CO INC NEW) | Long | Equity-common | US | $17M | 136K | 6.07 |
| Moderna, Inc. (Moderna Inc) | Long | Equity-common | US | $1M | 12K | 0.53 |
| Molina Healthcare, Inc. (Molina Healthcare Inc) | Long | Equity-common | US | $1M | 5K | 0.50 |
| Novo Nordisk AS ADR (Novo-Nordisk As Vormals Novoindustri As) | Long | Equity-common | DK | $3M | 18K | 0.94 |
| Option Care Health, Inc. (Option Care Health Inc) | Long | Equity-common | US | $1M | 45K | 0.45 |
| Pfizer, Inc. (Pfizer Inc) | Long | Equity-common | US | $7M | 249K | 2.51 |
| Regeneron Pharmaceuticals, Inc. (Regeneron Pharmaceuticals Inc) | Long | Equity-common | US | $3M | 3K | 1.15 |
| Sarepta Therapeutics, Inc. (Sarepta Therapeutics Inc) | Long | Equity-common | US | $2M | 11K | 0.61 |
| SPDR S&P Biotech ETF (Spdr Series Tr) | Long | Registered Investment Company | US | $825K | 9K | 0.30 |
| Stryker Corporation | Long | Equity-common | US | $3M | 9K | 1.12 |
| Teva Pharmaceutical Industries, Ltd. ADR (Teva Pharmaceutical Inds Ltd) | Long | Equity-common | IL | $2M | 105K | 0.61 |
| Thermo Fisher Scientific, Inc. (Thermo Fisher Scientific Inc) | Long | Equity-common | US | $8M | 15K | 2.92 |
| Thrivent Core Short-Term Reserve Fund (Thrivent Mutual Funds) | Long | Short-term investment vehicle | US | $888K | 89K | 0.32 |
| UnitedHealth Group, Inc. (Unitedhealth Group Inc) | Long | Equity-common | US | $24M | 48K | 8.73 |
| Universal Health Services, Inc. (UnIVersal Health Svcs Inc) | Long | Equity-common | US | $3M | 17K | 1.16 |
| Vertex Pharmaceuticals, Inc. (Vertex Pharmaceuticals Inc) | Long | Equity-common | US | $8M | 16K | 2.77 |
| Zimmer Biomet Holdings, Inc. (Zimmer Holdings Inc) | Long | Equity-common | US | $5M | 43K | 1.69 |
| Zoetis, Inc. (Zoetis Inc) | Long | Equity-common | US | $4M | 21K | 1.32 |
Address
Thrivent Series Fund Inc
901 Marquette Avenue
Suite 2500
Minneapolis
Minnesota
55402-3211
United States of America
Websites
Directors
James A. Nussle
James W. Runcie
Robert J. Chersi
Janice B. Case
Paul R. Laubscher
Arleas Upton Kea
Michael W. Kremenak
Constance L. Souders
David S. Royal
Robert J. Manilla
Transfer Agents
SS&C GIDS, Inc.
Thrivent Financial Investor Services Inc.
Pricing Services
S&P Global Inc.
ICE Data Pricing & Reference Data, LLC
Bloomberg L.P.
PricingDirect Inc.
Custodians
State Street Bank and Trust Company
Shareholder Servicing Agents
SS&C GIDS, Inc.
Thrivent Financial Investor Services Inc.
Admins
Thrivent Financial For Lutherans
Brokers
BOFA SECURITIES, INC.
J.P. MORGAN SECURITIES LLC
SANFORD C. BERNSTEIN & CO., LLC
ROBERT W. BAIRD & CO. INCORPORATED
RBC CAPITAL MARKETS, LLC
JEFFERIES LLC
PIPER SANDLER & CO.
BMO CAPITAL MARKETS CORP.
MORGAN STANLEY & CO. LLC
GOLDMAN SACHS & CO. LLC